Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Apr 15, 2020; 12(4): 365-382
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.365
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.365
Figure 5 Mesenchymal stem cells promote colorectal cancer progression via CCR5[99].
A: Scheme of co-inoculation mice model. HCT116-EV, HCT116 cells transfected with empty vector; HCT116-CCR5, HCT116 cells transfected with CCR5. B: Tumor volume curves in HCT116-EV and HCT116-CCR5 co-cultured with MSCs. C: Representative images of tumors and histological findings in HCT116-EV + MSCs and HCT116-CCR5 + MSCs groups. D: Scheme of treatment procedure. E: Tumor volume curves in HCT116-EV + MSCs and HCT116-CCR5 + MSCs groups. Dotted lines show treatment group with maraviroc 30 mg/kg/d, and solid lines show control group with vehicles.
- Citation: Li JN, Li W, Cao LQ, Liu N, Zhang K. Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies. World J Gastrointest Oncol 2020; 12(4): 365-382
- URL: https://www.wjgnet.com/1948-5204/full/v12/i4/365.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i4.365